Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 143 No. 0304 (2013)

Metabolomics – a novel window into inflammatory disease

  • Martin A Fitzpatrick
  • Stephen P. Young
DOI
https://doi.org/10.4414/smw.2013.13743
Cite this as:
Swiss Med Wkly. 2013;143:w13743
Published
13.01.2013

Summary

Inflammation is an important component of normal responses to infection and injury. However, chronic activation of the immune system, due to aberrant responses to normal stimuli, can lead to the establishment of a persistent inflammatory state. Such inflammatory conditions are often debilitating, and are associated with a number of important co-morbidities including cardiovascular disease. Resting non-proliferative tissues have distinctive metabolic activities and requirements, which differ considerably from those in infiltrating immune cells, which are undergoing proliferation and differentiation. Immune responses in tissues may therefore be modulated by the relative abundance of substrates in the inflamed site. In turn immune cell activity can feed back and affect metabolic behaviour of the tissues, as most clearly demonstrated in cachexia – the loss of cellular mass driven by tumour necrosis factor-alpha (TNF-α) a key mediator of the inflammatory response. Here we discuss the potential for metabolomic analysis to clarify the interactions between inflammation and metabolic changes underlying many diseases. We suggest that an increased understanding of the interaction between inflammation and cellular metabolism, energy substrate use, tissue breakdown markers, the microbiome and drug metabolites, may provide novel insight into the regulation of inflammatory diseases.

References

  1. Hassan MQ, Hadi R, Al-Rawi ZS, Padron V, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol. 2001;21(1):69–73.
  2. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;128(1):92–105.
  3. Leclerc V, Reichhart JM. The immune response of Drosophila melanogaster. Immunol Rev. 2004;198(1):59–71.
  4. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.
  5. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–49.
  6. Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010;6(8):445–51.
  7. Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ, Storr M. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. J Proteome Res. 2010;9(12):6265–73.
  8. Naughton DP, Haywood R, Blake DR, Edmonds S, Hawkes GE, Grootveld M. A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy. FEBS Lett. 1993;332(3):221–5.
  9. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, et al. NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases – a diagnostic tool? NMR Biomed. 2010;23(2):123–32.
  10. Ramadan Z, Jacobs D, Grigorov M, Kochhar S. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. Talanta. 2006;68(5):1683–91.
  11. Wu B, Yan S, Lin Z, Wang Q, Yang Y, Yang G, et al. Metabonomic study on ageing: NMR-based investigation into rat urinary metabolites and the effect of the total flavone of Epimedium. Mol Biosyst. 2008;4(8):855–61.
  12. Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M. An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Lett. 1993;317(1-2):135–8.
  13. Ng CT, Biniecka M, Kennedy A, McCormick J, Fitzgerald O, Bresnihan B, et al. Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis. 2010;69(7):1389–95.
  14. Gaber T, Häupl T, Sandig G, Tykwinska K, Fangradt M, Tschirschmann M, et al. Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis. J Rheumatol. 2009;36(12):2655–69.
  15. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645–57.
  16. Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, et al. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation. 2011;123(18):1986–95.
  17. Albina JE, Henry W, Mastrofrancesco B, Martin B, Reichner JS. Macrophage activiation by culture in an anoxic environment. J Immunol. 1995;(155):4391–6.
  18. Scannell G. Leukocyte responses to hypoxic/ischemic conditions. New Horiz. 1996;4(2):179–83.
  19. Murata Y, Ohteki T, Koyasu S, Hamuro J. IFN-γ and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension. Eur J Immunol. 2002;32(10):2866–73.
  20. White JR, Harris RA, Lee SR, Craigon MH, Binley K, Price T, et al. Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics. 2004;83(1):1–8.
  21. Lund-Olesen K. Oxygen tension in synovial fluids. Arthritis Rheum. 1970;13(6):769–76.
  22. Beyer C, Schett G, Gay S, Distler O, Distler JHW. Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther. 2009;11(2):220.
  23. Wheaton WW, Chandel NS. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol. 2011;300(3):C385–93.
  24. Warburg O, Negelein E. On the metabolism of cancer cells. Biochem Z. 1924;152:319–44.
  25. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.
  26. Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB. Brain metabolism during short-term starvation in humans. J Cereb Blood Flow Metab. 1994;14(1):125–31.
  27. Gerich JE. Physiology of glucose homeostasis. Diabetes Obes Metab. 2000;2(6):345–50.
  28. Wu GY, Field CJ, Marliss EB. Glutamine and glucose metabolism in rat splenocytes and mesenteric lymph node lymphocytes. Am J Physiol Endocrinol Metab. 1991;260(1):E141–147.
  29. Stjernholm RL, Burns CP, Hohnadel JH. Carbohydrate metabolism by leukocytes. Enzyme. 1972;13(1):7–31.
  30. Nicoli F, Vion-Dury J, Confort-Gouny S, Maillet S, Gastaut JL, Cozzone PJ. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. C R Acad Sci III. 1996;319(7):623–31.
  31. Malloy CR, Thompson JR, Jeffrey FM, Sherry D. Contribution of exogenous substrates to acetyl coenzyme A: measurement by 13C NMR under non-steady-state conditions. Biochemistry. 1990;29(29):6756–61.
  32. Lamers RJ, DeGroot J, Spies-Faber EJ, Jellema RH, Kraus VB, Verzijl N, et al. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic Guinea pigs. J Nutr. 2003;133(6):1776–80.
  33. Kinney JM. Energy metabolism: tissue determinants and cellular corollaries. Raven Press; 1992. p. 562.
  34. Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W, et al. Specific metabolic rates of major organs and tissues across adulthood : evaluation by mechanistic model of resting energy expenditure 1 – 4. Am J Clin Nutr. 2010;92(4):1369–77.
  35. Metsios GS, Stavropoulos-Kalinoglou A, Nevill M, Douglas KMJ, Koutedakis Y, Kitas GD. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67(1):70–3.
  36. Demas GE, Chefer V, Talan MI, Nelson RJ, Crommenacker JVD, Richardson DS, et al. Metabolic costs of mounting an antigen-stimulated immune response in adult and aged C57BL/6J mice. Am J Physiol. 1997;273(5):R1631–7.
  37. Benhariz M, Goulet O, Salas J, Colomb V, Ricour C. Energy cost of fever in children on total parenteral nutrition. Clin Nutr. 1997;16(5):251–5.
  38. Romanyukha A, Rudnev SG, Sidorov I. Energy cost of infection burden: an approach to understanding the dynamics of host-pathogen interactions. J Theor Biol. 2006;241(1):1–13.
  39. Chioléro R, Revelly JP, Tappy L. Energy metabolism in sepsis and injury. Nutrition. 1997;13(9 Suppl):45S–51S.
  40. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 2008;8(12):923–34.
  41. Lauridsen MB, Bliddal H, Christensen R, Danneskiold-samsøe B, Bennett R, Keun H, et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res. 2010;9(9):4545–53.
  42. Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions. Mol Immunol. 2008;45(12):3419–27.
  43. Lutz NW, Viola A, Malikova I, Confort-Gouny S, Ranjeva JP, Pelletier J, et al. A branched-chain organic acid linked to multiple sclerosis: first identification by NMR spectroscopy of CSF. Biochem Biophys Res Commun. 2007;354(1):160–4.
  44. Chitayat D, Meagher-Villemure K, Mamer OA, O’Gorman A, Hoar DI, Silver K, et al. Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. J Pediatr. 1992;121(1):86–9.
  45. Parkes HG, Grootveld MC, Henderson EB, Farrell A, Blake DR, Parke HG, et al. Oxidative damage to synovial fluid from the inflamed rheumatoid joint detected by 1H NMR spectroscopy. J Pharm Biomed Anal. 1991;9(1):75–82.
  46. Zhai G, Wang-Sattler R, Hart DJ, Arden NK, Hakim AJ, Illig T, et al. Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis. 2010;69(6):1227–31.
  47. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007;6(2):546–51.
  48. Lin H-M, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD. Nontargeted urinary metabolite profiling of a mouse model of Crohn’s disease. J Proteome Res. 2009;8(4):2045–57.
  49. Griffin JL, Anthony DC, Campbell SJ, Gauldie J, Pitossi F, Styles P, et al. Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine. FEBS Lett. 2004;568(1-3):49–54.
  50. Bassit R, Sawada L, Bacurau RFP, Navarro F, Martins E, Santos RVT, et al. Branched-chain amino acid supplementation and the immune response of long-distance athletes. Nutrition. 2002;18(5):376–9.
  51. Morris SM. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr. 2002;22(58):87–105.
  52. Young SP, Wallace GR. Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor. 2009;2(4):235–42.
  53. Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, Slupsky CM. Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. Anal Chem. 2008;80(14):5524–31.
  54. van Erk MJ, Wopereis S, Rubingh C, van Vliet T, Verheij E, Cnubben NHP, et al. Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. BMC Med Genomics. 2010;3:5.
  55. Kaddurah-Daouk R, Baillie R a, Zhu H, Zeng Z-B, Wiest MM, Nguyen UT, et al. Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. Metabolomics. 2010;6(2):191–201.
  56. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31(70):107–33.
  57. Williams HRT, Cox IJ, Walker DG, North BV, Patel VM, Marshall SE, et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol. 2009;104(6):1435–44.
  58. Brown CT, Davis-Richardson AG, Giongo A, Gano K, Crabb DB, Mukherjee N, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PloS One. 2011;6(10):e25792.
  59. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
  60. Weljie AM, Dowlatabadi R, Miller BJ, Vogel HJ, Jirik FR. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. J Proteome Res. 2007;6(9):3456–64.
  61. Schmelzer KR, Inceoglu B, Kubala L, Kim IH, Jinks SL, Eiserich JP, et al. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A. 2006;103(37):13646–51.
  62. Nuttall SL, Martin U, Sinclair AJ, Kendall MJ. Glutathione: in sickness and in health. Lancet. 1998;351(9103):645–6.